WO2005077962A3 - Crowned dithiocarbamate metal complexes and methods for their use - Google Patents

Crowned dithiocarbamate metal complexes and methods for their use Download PDF

Info

Publication number
WO2005077962A3
WO2005077962A3 PCT/US2005/004872 US2005004872W WO2005077962A3 WO 2005077962 A3 WO2005077962 A3 WO 2005077962A3 US 2005004872 W US2005004872 W US 2005004872W WO 2005077962 A3 WO2005077962 A3 WO 2005077962A3
Authority
WO
WIPO (PCT)
Prior art keywords
crowned
methods
complexes
dtcs
metal complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/004872
Other languages
French (fr)
Other versions
WO2005077962A2 (en
Inventor
Shuang Liu
Zhengjie He
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Research Foundation
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Priority to EP05726497A priority Critical patent/EP1718656A2/en
Priority to US10/588,343 priority patent/US20070166227A1/en
Publication of WO2005077962A2 publication Critical patent/WO2005077962A2/en
Publication of WO2005077962A3 publication Critical patent/WO2005077962A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/0412—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K51/0423—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0476—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Compositions containing crowned dithiocarbamate metal complexes and methods of using these compositions; neutral and cationic radioactive metal-nitrido complexes of crowned dithiocarbamates (DTCs) and methods of using these complexes as radiopharmaceuticals for diagnosis and treatment of cardiovascular disorders, infectious diseases, and cancer; tripodal chelator­metal complexes of crowned DTCs and methods of using these complexes for treating diseases such as those characterized by nitric oxide overproduction; and methods of using crowned DTCs for heavy metal detoxification are described.
PCT/US2005/004872 2004-02-10 2005-02-10 Crowned dithiocarbamate metal complexes and methods for their use Ceased WO2005077962A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP05726497A EP1718656A2 (en) 2004-02-10 2005-02-10 Crowned dithiocarbamate metal complexes and methods for their use
US10/588,343 US20070166227A1 (en) 2004-02-10 2005-02-10 Crowned dithiocarbamate metal complexes and methods for their use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54317604P 2004-02-10 2004-02-10
US60/543,176 2004-02-10

Publications (2)

Publication Number Publication Date
WO2005077962A2 WO2005077962A2 (en) 2005-08-25
WO2005077962A3 true WO2005077962A3 (en) 2005-12-15

Family

ID=34860386

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/004872 Ceased WO2005077962A2 (en) 2004-02-10 2005-02-10 Crowned dithiocarbamate metal complexes and methods for their use

Country Status (3)

Country Link
US (1) US20070166227A1 (en)
EP (1) EP1718656A2 (en)
WO (1) WO2005077962A2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8282967B2 (en) 2005-05-27 2012-10-09 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
US8981139B2 (en) 2011-02-28 2015-03-17 The University Of North Carolina At Chapel Hill Tertiary S-nitrosothiol-modified nitric—oxide-releasing xerogels and methods of using the same
US9526738B2 (en) 2009-08-21 2016-12-27 Novan, Inc. Topical gels and methods of using the same
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8036731B2 (en) 2001-01-22 2011-10-11 Spectrum Dynamics Llc Ingestible pill for diagnosing a gastrointestinal tract
US8909325B2 (en) 2000-08-21 2014-12-09 Biosensors International Group, Ltd. Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures
US8489176B1 (en) 2000-08-21 2013-07-16 Spectrum Dynamics Llc Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures
US8565860B2 (en) 2000-08-21 2013-10-22 Biosensors International Group, Ltd. Radioactive emission detector equipped with a position tracking system
WO2002058531A2 (en) 2001-01-22 2002-08-01 V-Target Technologies Ltd. Ingestible device
US9470801B2 (en) 2004-01-13 2016-10-18 Spectrum Dynamics Llc Gating with anatomically varying durations
US8586932B2 (en) 2004-11-09 2013-11-19 Spectrum Dynamics Llc System and method for radioactive emission measurement
EP1709585B1 (en) 2004-01-13 2020-01-08 Spectrum Dynamics Medical Limited Multi-dimensional image reconstruction
US9040016B2 (en) 2004-01-13 2015-05-26 Biosensors International Group, Ltd. Diagnostic kit and methods for radioimaging myocardial perfusion
US8571881B2 (en) 2004-11-09 2013-10-29 Spectrum Dynamics, Llc Radiopharmaceutical dispensing, administration, and imaging
US7968851B2 (en) 2004-01-13 2011-06-28 Spectrum Dynamics Llc Dynamic spect camera
US10964075B2 (en) 2004-01-13 2021-03-30 Spectrum Dynamics Llc Gating with anatomically varying durations
US8280124B2 (en) * 2004-06-01 2012-10-02 Spectrum Dynamics Llc Methods of view selection for radioactive emission measurements
EP1778957A4 (en) 2004-06-01 2015-12-23 Biosensors Int Group Ltd OPTIMIZING THE MEASUREMENT OF RADIOACTIVE EMISSIONS IN SPECIFIC BODY STRUCTURES
TWI359810B (en) 2004-11-04 2012-03-11 Mitsubishi Tanabe Pharma Corp Carboxylic acid derivative containing thiazole rin
US8000773B2 (en) 2004-11-09 2011-08-16 Spectrum Dynamics Llc Radioimaging
US9316743B2 (en) 2004-11-09 2016-04-19 Biosensors International Group, Ltd. System and method for radioactive emission measurement
US8606349B2 (en) 2004-11-09 2013-12-10 Biosensors International Group, Ltd. Radioimaging using low dose isotope
US8615405B2 (en) 2004-11-09 2013-12-24 Biosensors International Group, Ltd. Imaging system customization using data from radiopharmaceutical-associated data carrier
US10136865B2 (en) 2004-11-09 2018-11-27 Spectrum Dynamics Medical Limited Radioimaging using low dose isotope
WO2008059489A2 (en) 2006-11-13 2008-05-22 Spectrum Dynamics Llc Radioimaging applications of and novel formulations of teboroxime
EP1844351A4 (en) * 2005-01-13 2017-07-05 Biosensors International Group, Ltd. Multi-dimensional image reconstruction and analysis for expert-system diagnosis
EP1909853B1 (en) 2005-07-19 2015-03-18 Biosensors International Group, Ltd. Imaging protocols
US8837793B2 (en) 2005-07-19 2014-09-16 Biosensors International Group, Ltd. Reconstruction stabilizer and active vision
US7705316B2 (en) 2005-11-09 2010-04-27 Spectrum Dynamics Llc Dynamic SPECT camera
US8204500B2 (en) 2005-12-28 2012-06-19 Starhome Gmbh Optimal voicemail deposit for roaming cellular telephony
US8894974B2 (en) 2006-05-11 2014-11-25 Spectrum Dynamics Llc Radiopharmaceuticals for diagnosis and therapy
GB0623482D0 (en) * 2006-11-24 2007-01-03 Mallinckrodt Inc Technetium-99m (l) tricarbonyl complexes with tridentate chelators for myocardium imaging
WO2008075362A2 (en) 2006-12-20 2008-06-26 Spectrum Dynamics Llc A method, a system, and an apparatus for using and processing multidimensional data
US7708961B2 (en) 2007-03-31 2010-05-04 Advanced Applied Physics Solutions, Inc. Method and apparatus for isolating the radioisotope 186Rhenium
US8521253B2 (en) 2007-10-29 2013-08-27 Spectrum Dynamics Llc Prostate imaging
CU23844B1 (en) * 2009-04-17 2012-10-15 Ct De Neurociencias De Cuba PROCEDURE FOR OBTAINING NEW DERIVATIVES OF NAFTALENE FOR THE LIVE DIAGNOSIS OF ALZHEIMER'S DISEASE
US8338788B2 (en) 2009-07-29 2012-12-25 Spectrum Dynamics Llc Method and system of optimized volumetric imaging
US9587292B2 (en) 2009-10-01 2017-03-07 Advanced Applied Physics Solutions, Inc. Method and apparatus for isolating the radioisotope molybdenum-99
CN106588729B (en) * 2016-12-06 2021-05-28 青岛柏森环保工程有限公司 Preparation method of polythiohydrazide type heavy metal chelating agent

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6322771B1 (en) * 1999-06-18 2001-11-27 University Of Virginia Patent Foundation Induction of pharmacological stress with adenosine receptor agonists

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6322771B1 (en) * 1999-06-18 2001-11-27 University Of Virginia Patent Foundation Induction of pharmacological stress with adenosine receptor agonists

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
CAMERON, B ET AL.: "Ruthenium (III) Triazacyclononane Dithiocarbamate...", INORGANIC CHEMISTRY, vol. 42, no. 13, 2003, pages 4102 - 4108, XP002335490 *
DATABASE BEILSTEIN [online] BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; 23 October 1991 (1991-10-23), XP002332644, Database accession no. BRN 3580252; BRN3582715 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; BERRY, NEIL G. ET AL: "Heteroditopic transition metal dithiocarbamate receptors for binding cation-anion ion pairs", XP002332544, retrieved from STN Database accession no. 2003:732428 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; GRANELL, JAUME ET AL: "Studies on the synthesis and electrochemistry of crown ether dithiocarbamates and the molecular dynamics of bis(aza-15-crown- 5)thiuram disulfide. Crystal structure of cobalt tris[(aza-15-crown-5)dithiocarbamate]", XP002332545, retrieved from STN Database accession no. 1990:490225 *
DIAZ ET AL.: "Interactions of nitric ocide with copper (II) dithiocarbamates in aqueous solution", JOURNAL OF INORGANIC BIOCHEMISTRY, no. 95, 2003, pages 283 - 290, XP002335489 *
JOURNAL OF SUPRAMOLECULAR CHEMISTRY , VOLUME DATE 2002, 2(1-3), 89-92 CODEN: JSCOC9; ISSN: 1472-7862, 2003 *
JOURNAL OF THE CHEMICAL SOCIETY, DALTON TRANSACTIONS: INORGANIC CHEMISTRY (1972-1999) , (2), 605-14 CODEN: JCDTBI; ISSN: 0300-9246, 1990 *
SCHRAMM D ET AL: "SYNTHESIS OF CATIONIC HYDROTRIS(PYRAZOLYL)BORATE ZIRCONIUM COMPOUNDS", INTERNATIONAL CONFERENCE ON ORGANOMETALLIC CHEMISTRY. BOOK OF ABSTRACTS, 16 August 1998 (1998-08-16), pages A150, XP002249590 *
VÖGTLE, FRITZ, NEUMANN, PETER: "Stereochemie im Innern cyclischer Verbindungen: Kronenäther, Katapinate und Kryptate", CHEMIKER-ZEITUNG, vol. 97, no. 11, 1973, pages 600 - 610, XP002335491 *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9403851B2 (en) 2005-05-27 2016-08-02 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
US8282967B2 (en) 2005-05-27 2012-10-09 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
US8956658B2 (en) 2005-05-27 2015-02-17 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
US8962029B2 (en) 2005-05-27 2015-02-24 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
US11691995B2 (en) 2005-05-27 2023-07-04 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
US9403852B2 (en) 2005-05-27 2016-08-02 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
US11583608B2 (en) 2009-08-21 2023-02-21 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
US9737561B2 (en) 2009-08-21 2017-08-22 Novan, Inc. Topical gels and methods of using the same
US10376538B2 (en) 2009-08-21 2019-08-13 Novan, Inc. Topical gels and methods of using the same
US9526738B2 (en) 2009-08-21 2016-12-27 Novan, Inc. Topical gels and methods of using the same
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
US9713652B2 (en) 2011-02-28 2017-07-25 The University Of North Carolina At Chapel Hill Nitric oxide-releasing S-nitrosothiol-modified silica particles and methods of making the same
US8981139B2 (en) 2011-02-28 2015-03-17 The University Of North Carolina At Chapel Hill Tertiary S-nitrosothiol-modified nitric—oxide-releasing xerogels and methods of using the same

Also Published As

Publication number Publication date
US20070166227A1 (en) 2007-07-19
WO2005077962A2 (en) 2005-08-25
EP1718656A2 (en) 2006-11-08

Similar Documents

Publication Publication Date Title
Jiang et al. Cr (VI) adsorption and reduction by humic acid coated on magnetite
IL180677A0 (en) Compounds, compositions and methods for treatment of hyperproliferative diseases, such as cancer
WO2006107451A3 (en) Honokiol derivatives for the treatment of proliferative disorders
WO2004063355A3 (en) Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer
WO2005111211A3 (en) Micronas and uses thereof
EP4691558A3 (en) Treatment or prophylaxis of proliferative conditions
WO2003008583A3 (en) Novel compositions and methods for cancer
WO2008092590A3 (en) Particulate uv protection agent
WO2011021203A3 (en) Desferrioxamine-metal complexes for the treatment of immune-related disorders
WO2004071382A3 (en) Substituted heterocycles
WO2010065329A3 (en) Nanoparticles for cancer treatment
WO2009063912A1 (en) Curable composition and method for producing urethane (meth)acrylate
GB0718878D0 (en) Photodynamic Theraphy and diagnosis
WO2005085266A8 (en) Macrocyclic compounds and methods of making and using the same
WO2003045230A3 (en) Novel compositions and methods for cancer
WO2007046097A3 (en) Topical compositions for the treatment of depilation-induced skin irritation or prevention thereof
WO2005049520A3 (en) Method for solubilizing metal oxides by surface treatment, surface treated metal oxide solutions and method for separating metal oxides
MY142036A (en) New quaternized quinuclidine esters
WO2003053224A3 (en) Novel compositions and methods for cancer
WO2007025284A8 (en) Triazole compounds and methods of making and using the same
WO2008092002A3 (en) Compositions and methods for treating and diagnosing pancreatic cancer
WO2010130825A3 (en) New targets for cancer therapy and/or diagnosis and new screening tools
WO2007076087A3 (en) 3-aryl-substituted quinazolones, and uses thereof
AU2003290127A1 (en) 4-amino-7,8-dihydropteridines, pharmaceutical compositions containing them and their use for the treatment of diseases which are caused by an increased nitric oxide level
EP4138811A4 (en) COMPOSITION, KIT AND METHOD FOR DIAGNOSIS AND TREATMENT OF PROSTATE CANCER

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2007166227

Country of ref document: US

Ref document number: 10588343

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2005726497

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWP Wipo information: published in national office

Ref document number: 2005726497

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 10588343

Country of ref document: US